TNFSF11 and prostate carcinoma: Immunohistochemistry analyses (Figure10) confirmed the observations shown in Figure9 in the following aspects: a) RANKL expression increases in prostate cancer tissue (Figure10B) as compared with normal tissue (Figure10A).